XPO1 inhibitor

DRUG2 trials

Sponsors

Chinese PLA General Hospital, Beijing Tongren Hospital

Conditions

Advanced LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Newly DiagnosedPrimary Central Nervous System Lymphoma (PCNSL)nk/T-cell Lymphoma

Phase 2

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

RecruitingNCT05833893

Chinese PLA General HospitalAdvanced Lymphoma, Newly Diagnosed, nk/T-cell Lymphoma

Start: 2023-05-01End: 2026-12-31Target: 10Updated: 2023-04-27

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

RecruitingNCT07523737

Beijing Tongren HospitalDiffuse Large B Cell Lymphoma (DLBCL), Primary Central Nervous System Lymphoma (PCNSL)

Start: 2026-04-01End: 2028-08-31Target: 43Updated: 2026-04-15